| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.26 | 5e-06 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.25 | 5e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0001 |